Improvement after a supplement is not the same as a comparative result
Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.
Vitamin E
Selected research topic
Immune and respiratory health
Some publications still need interpretation checks and are kept separate from the findings below.
- Publications for this topic
- 7
- Human comparison publications
- 0
- Publications needing review
- 7
This result is held for interpretation. That does not mean research found no effect.
Outcome groups needing additional review (7)
- cytokine production · Distinct papers needing additional review: 1Direction unclear: 1
- disease symptoms · Distinct papers needing additional review: 1Evidence criteria check: 1
- immune boosting · Distinct papers needing additional review: 1Evidence criteria check: 1
- inflammation markers · Distinct papers needing additional review: 1Evidence criteria check: 1
- inflammatory response · Distinct papers needing additional review: 1Evidence criteria check: 1
- liver anti-inflammatory factors · Distinct papers needing additional review: 1Evidence criteria check: 1
- lung inflammation · Distinct papers needing additional review: 1Evidence criteria check: 1
One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.
Representative outcome and study details
Some findings are held for review
Some papers have not cleared source or result review, so their findings are not summarized yet.
No confirmed result is available to summarize with study conditions.
1 publications linked to this result (1 awaiting review included)
- Those papers are not summarized until review is complete.
Data coverage and detailed study classifications
Paper counts are separated by research topic below. One paper may contribute to multiple findings.
Analysis status: Public-ready
Ingredient analysis date:
How the grade was determined: C
The 31.7 evidence score includes 0 independent human studies and 0 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.
The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.
Papers linked to this ingredient overall: 131
Papers linked to this topic 7 · distinct papers 7 · comparison findings need further review · papers needing additional review 7
A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.
- cytokine production: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- disease symptoms: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- immune boosting: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- inflammation markers: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- inflammatory response: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- liver anti-inflammatory factors: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- lung inflammation: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
What the research found
cytokine production
The study needs further checking before its result can be interpreted.
Other evidence · Single ingredient · Patient group
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
disease symptoms
The study needs further checking before its result can be interpreted.
Review · Unknown intervention · Patient group
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
immune boosting
The study needs further checking before its result can be interpreted.
Review · Single ingredient · Patient group
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
inflammation markers
The study needs further checking before its result can be interpreted.
Review · Unknown intervention · Patient group
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
inflammatory response
The study needs further checking before its result can be interpreted.
Animal study · indirect · Single ingredient · Patient group
This finding comes from animal or cell research. It does not establish the same effect in people.
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
liver anti-inflammatory factors
The study needs further checking before its result can be interpreted.
Animal study · indirect · Single ingredient · Patient group
This finding comes from animal or cell research. It does not establish the same effect in people.
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
lung inflammation
The study needs further checking before its result can be interpreted.
Animal study · indirect · Separable contribution · General population
This finding comes from animal or cell research. It does not establish the same effect in people.
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
Unspecified measured outcome
The study needs further checking before its result can be interpreted.
Controlled study in people · Single ingredient · Patient group
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
How to read research findings
How should I read research findings?
Research guidesNo clear difference and an uninterpretable result are different
A reported null comparison contains a result. An abstract without an interpretable comparison leaves a question unresolved.
Paper counts and study counts are different
Count original research separately from research that reanalyzes it. Publication volume is neither replication nor a quality rating.
Side effects and combination findings
Findings from this ingredient alone are shown separately from those involving another supplement or medication.
No reviewed caution rules are available yet. Reported caution findings are shown below.
Review 2 combination findings and 0 findings that outperformed an ingredient alone.
Findings to review with care
Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.
Cautions reported with another supplement or medication
These studies reported worsening outcomes, reduced absorption, or other cautions with combined use. They do not predict an individual's outcome.
와파린Vitamin E's anticoagulant effects amplify the risk of bleeding when combined with blood thinners like warfarin.
AspirinVitamin E's anticoagulant effects amplify the risk of bleeding when combined with blood thinners like aspirin.
Reported improvements with combinations
Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.
Combinations with reported improvement
The combination showed improvement, but each ingredient's contribution is unclear.
비타민 CIn a triple-blind RCT of 60 women with endometriosis, a combination of Vitamin C (1000 mg/day) and Vitamin E (800 IU/day) for 8 weeks significantly reduced pelvic pain, dysmenorrhea, and dyspareunia compared to placebo.
인삼The combined supplement significantly improved the desire domain of the FSFI compared to placebo.